Snížení srdeční frekvence u srdečního selhání - studie SHIFT

Warning

This publication doesn't include Faculty of Arts. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Title in English Reducing heart rate in heart failure - the SHIFT Study
Authors

VÍTOVEC Jiří ŠPINAR Jindřich

Year of publication 2011
Type Article in Periodical
Magazine / Source Postgraduální medicína
MU Faculty or unit

Faculty of Medicine

Citation
Field Cardiovascular diseases incl. cardiosurgery
Keywords ivabradine;heart rate; heart failure
Description Many surveillance studies have shown that heart rate (HR) above 70/min worsens the prognosis of patients with cardiovascular disease. There is a series of drugs that reduce the HR, but not quite enough on one side and on the other side they have many side effects. Recently a specific inhibitor of the If channel -ivabradine has been tested. The authors report on its effect in heart failure on 6558 patients with heart failure of ischemic and nonischemic etiology, NYHA II-IV, with heart rate of 70/min, who had optimal treatment of heart failure, including beta-blockers, in the Shift study. Ivabradine dosed 2 times 5 to 7.5 mg was compared to placebo. The result was a significant reduction in the incidence of the primary goal - a total decrease of hospitalizations for heart failure and cardiovascular mortality of 18% in favor of ivabradine. Also, a decrease of deaths for heart failure was reduced by 26% in the active treatment group. Ivabradine was well tolerated, similar to placebo.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.